camzyos
bristol-myers squibb pharma eeig - mavacamten - cardiomyopathy, hypertrophic - andra hjärtpreparat - treatment of symptomatic obstructive hypertrophic cardiomyopathy.
symbicort 160 mikrogram/4,5 mikrogram/puff inhalationsspray, suspension
astrazeneca ab - budesonid; formoterolfumaratdihydrat - inhalationsspray, suspension - 160 mikrogram/4,5 mikrogram/puff - budesonid 160 mikrog aktiv substans; formoterolfumaratdihydrat 4,5 mikrog aktiv substans